HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anton Hagenbeek Selected Research

Anton Hagenbeek Research Topics

Disease

22Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2019 - 11/2002
16Neoplasms (Cancer)
10/2021 - 11/2002
13Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2019 - 11/2002
9Lymphoma (Lymphomas)
12/2019 - 11/2002
8Hodgkin Disease (Hodgkin's Disease)
10/2021 - 06/2003
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2019 - 01/2003
5Graft vs Host Disease (Graft-Versus-Host Disease)
01/2007 - 01/2002
3B-Cell Lymphoma (Lymphoma, B Cell)
06/2011 - 06/2008
2Residual Neoplasm
10/2021 - 11/2009
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
06/2015 - 02/2009
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
07/2014 - 06/2008
2Infections
06/2010 - 04/2006
2Pathologic Complete Response
06/2010 - 06/2003
2Leukemia
03/2005 - 05/2003
1Fever (Fevers)
01/2021
1Ototoxicity
01/2021
1Disease Progression
05/2019
1Febrile Neutropenia
06/2015
1Neutropenia
06/2015
1Rheumatoid Arthritis
07/2014
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
02/2013
1Bronchiolitis Obliterans Syndrome
11/2008
1Agranulocytosis (Granulocytopenia)
04/2006
1Hematologic Neoplasms (Hematological Malignancy)
03/2006
1GATA2 Deficiency
01/2003

Drug/Important Bio-Agent (IBA)

19Rituximab (Mabthera)FDA Link
05/2019 - 11/2002
7Biomarkers (Surrogate Marker)IBA
12/2019 - 03/2007
7Vincristine (Oncovin)FDA LinkGeneric
01/2017 - 01/2003
7Prednisone (Sone)FDA LinkGeneric
01/2017 - 01/2003
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 01/2003
6Monoclonal AntibodiesIBA
07/2014 - 06/2008
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 01/2003
4Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 02/2009
4ofatumumabFDA Link
02/2017 - 06/2008
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 02/2017
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 02/2017
3ibritumomab tiuxetan (Zevalin)FDA Link
06/2013 - 11/2008
3Yttrium-90IBA
06/2013 - 11/2008
3AntibodiesIBA
06/2011 - 07/2006
3fludarabineIBA
01/2009 - 02/2005
3Ganciclovir (Cytovene)FDA LinkGeneric
10/2004 - 03/2003
2Brentuximab VedotinIBA
01/2021 - 01/2019
2polatuzumab vedotinIBA
05/2019 - 06/2015
2Biological ProductsIBA
04/2014 - 04/2009
2Complement System Proteins (Complement)IBA
02/2013 - 06/2008
2EpitopesIBA
12/2010 - 05/2005
2CD20 AntigensIBA
08/2010 - 04/2010
2AntigensIBA
01/2007 - 06/2003
2Therapeutic UsesIBA
01/2007 - 06/2003
2Thymidine KinaseIBA
05/2003 - 03/2003
1Cell-Free Nucleic AcidsIBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2021
1EnzymesIBA
01/2021
1pinatuzumab vedotinIBA
05/2019
1Genetic Markers (Genetic Marker)IBA
01/2017
1Immunoconjugates (Immunoconjugate)IBA
06/2015
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2010
1IsoantibodiesIBA
11/2008
1AutoantibodiesIBA
11/2008
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
06/2008
1Pharmaceutical PreparationsIBA
02/2007
1fludarabine phosphate (Fludara)FDA LinkGeneric
04/2006
1Procarbazine (Matulane)FDA Link
06/2003
1Vinblastine (Vinblastine Sulfate)FDA Link
06/2003
1Mechlorethamine (Nitrogen Mustard)FDA Link
06/2003
1Bleomycin (Blenoxane)FDA LinkGeneric
06/2003
1Alkylating AgentsIBA
01/2003
1Mitoxantrone (Novantrone)FDA LinkGeneric
11/2002
1Prednisolone (Predate)FDA LinkGeneric
11/2002
1Chlorambucil (Leukeran)FDA Link
11/2002

Therapy/Procedure

13Drug Therapy (Chemotherapy)
01/2021 - 01/2003
12Therapeutics
02/2017 - 11/2002
4Salvage Therapy
01/2021 - 01/2007
4Stem Cell Transplantation
02/2017 - 05/2003
3Radiotherapy
11/2007 - 06/2003
2Aftercare (After-Treatment)
10/2021 - 12/2009
2Remission Induction
06/2010 - 11/2006
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2004 - 01/2002
1Immunotherapy
11/2008
1Hematopoietic Stem Cell Transplantation
11/2008
1Combined Modality Therapy
07/2006
1Radioimmunotherapy
02/2005
1Transplantation
01/2003